204 related articles for article (PubMed ID: 2200657)
1. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
Yurochko AD; Burger CJ; Elgert KD
Cytometry; 1990; 11(6):725-35. PubMed ID: 2200657
[TBL] [Abstract][Full Text] [Related]
2. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages.
Askew D; Burger CJ; Elgert KD
Immunobiology; 1990 Dec; 182(1):1-10. PubMed ID: 2151512
[TBL] [Abstract][Full Text] [Related]
3. Changes in macrophage populations: phenotypic differences between normal and tumor-bearing host macrophages.
Yurochko AD; Pyle RH; Elgert KD
Immunobiology; 1989 Feb; 178(4-5):416-35. PubMed ID: 2654009
[TBL] [Abstract][Full Text] [Related]
4. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics.
Askew D; Yurochko AD; Burger CJ; Elgert KD
Immunol Lett; 1990; 24(1):21-9. PubMed ID: 1695610
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth changes responsiveness to and production of granulocyte-macrophage colony-stimulating factor during recognition of self MHC class II molecules.
Walker TM; Burger CJ; Elgert KD
Oncol Res; 1992; 4(11-12):455-65. PubMed ID: 1299376
[TBL] [Abstract][Full Text] [Related]
6. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunol Lett; 1992 Feb; 31(3):217-25. PubMed ID: 1548036
[TBL] [Abstract][Full Text] [Related]
7. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
Garner RE; Malick AP; Elgert KD
J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
9. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity.
Garner RE; Malick AP; Yurochko AD; Elgert KD
Cell Immunol; 1987 Sep; 108(2):255-68. PubMed ID: 2957065
[TBL] [Abstract][Full Text] [Related]
10. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition.
Walker TM; Yurochko AD; Burger CJ; Elgert KD
Immunobiology; 1992 Sep; 185(5):427-39. PubMed ID: 1452214
[TBL] [Abstract][Full Text] [Related]
11. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide.
Yurochko AD; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1990 Feb; 19(1):41-55. PubMed ID: 1692569
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.
Malick AP; Elgert KD; Garner RE; Adkinson NF
J Leukoc Biol; 1987 Dec; 42(6):673-81. PubMed ID: 2960767
[TBL] [Abstract][Full Text] [Related]
13. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
Alleva DG; Elgert KD
Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
Alleva DG; Burger CJ; Elgert KD
J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression.
Askew D; Burger CJ; Elgert KD
Mol Immunol; 1993 Jul; 30(10):911-20. PubMed ID: 8341283
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal and splenic macrophage functions in the tumor-bearing host.
Gardner TE; Naama H; Daly JM
J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
[TBL] [Abstract][Full Text] [Related]
17. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
Alleva DG; Burger CJ; Elgert KD
Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
[TBL] [Abstract][Full Text] [Related]
19. Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages.
Boraschi D; Niederhuber JE
J Immunol; 1982 Nov; 129(5):1854-8. PubMed ID: 6956630
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth and adherence change the expression of macrophage Mac-2.
Askew D; Burger CJ; Elgert KD
Cancer Lett; 1993 Apr; 69(1):67-74. PubMed ID: 8481895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
